Description
Liraglutide is a UK-licensed weight loss injection designed to help patients reduce their appetite, control cravings, and achieve long-term weight loss. It is a GLP-1 receptor agonist that mimics the body’s natural appetite-regulating hormone.
Marketed as Saxenda for weight management, Liraglutide is available for those with:
- BMI of 30+ (classified as obese)
- BMI of 27+ with a weight-related condition such as high blood pressure, diabetes, or high cholesterol
Liraglutide is also available as Victoza, a lower-dose version used for type 2 diabetes treatment.
Reviews
There are no reviews yet.